9EPL image
Entry Detail
PDB ID:
9EPL
Keywords:
Title:
Mpro from SARS-CoV-2 with 298Q mutation
Biological Source:
PDB Version:
Deposition Date:
2024-03-18
Release Date:
2024-04-17
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.22
R-Value Work:
0.14
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Non-structural protein 11
Mutations:R298Q
Chain IDs:A
Chain Length:300
Number of Molecules:1
Biological Source:Severe acute respiratory syndrome coronavirus 2
Primary Citation
SARS-CoV-2 M pro oligomerization as a potential target for therapy.
Int.J.Biol.Macromol. 267 131392 131392 (2024)
PMID: 38582483 DOI: 10.1016/j.ijbiomac.2024.131392

Abstact

The main protease (Mpro) of SARS-CoV-2 is critical in the virus's replication cycle, facilitating the maturation of polyproteins into functional units. Due to its conservation across taxa, Mpro is a promising target for broad-spectrum antiviral drugs. Targeting Mpro with small molecule inhibitors, such as nirmatrelvir combined with ritonavir (Paxlovid™), which the FDA has approved for post-exposure treatment and prophylaxis, can effectively interrupt the replication process of the virus. A key aspect of Mpro's function is its ability to form a functional dimer. However, the mechanics of dimerization and its influence on proteolytic activity remain less understood. In this study, we utilized biochemical, structural, and molecular modelling approaches to explore Mpro dimerization. We evaluated critical residues, specifically Arg4 and Arg298, that are essential for dimerization. Our results show that changes in the oligomerization state of Mpro directly affect its enzymatic activity and dimerization propensity. We discovered a synergistic relationship influencing dimer formation, involving both intra- and intermolecular interactions. These findings highlight the potential for developing allosteric inhibitors targeting Mpro, offering promising new directions for therapeutic strategies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures